MENU
+Compare
MGNX
Stock ticker: NASDAQ
AS OF
Nov 24, 01:35 PM (EDT)
Price
$1.43
Change
+$0.03 (+2.14%)
Capitalization
88.56M

MGNX MacroGenics Forecast, Technical & Fundamental Analysis

Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer... Show more

Industry: #Biotechnology
MGNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for MGNX with price predictions
Nov 21, 2025

MGNX sees MACD Histogram just turned negative

MGNX saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 19, 2025. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 52 instances where the indicator turned negative. In of the 52 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

MGNX moved below its 50-day moving average on October 29, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MGNX crossed bearishly below the 50-day moving average on November 05, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

MGNX broke above its upper Bollinger Band on October 21, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MGNX's RSI Oscillator exited the oversold zone, of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Momentum Indicator moved above the 0 level on November 20, 2025. You may want to consider a long position or call options on MGNX as a result. In of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MGNX advanced for three days, in of 277 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 150 cases where MGNX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.322) is normal, around the industry mean (27.249). P/E Ratio (0.000) is within average values for comparable stocks, (51.596). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.881). Dividend Yield (0.000) settles around the average of (0.047) among similar stocks. P/S Ratio (0.700) is also within normal values, averaging (320.418).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. MGNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGNX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MGNX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

MGNX is expected to report earnings to fall 199.85% to -26 cents per share on February 19

MacroGenics MGNX Stock Earnings Reports
Q4'25
Est.
$-0.27
Q3'25
Beat
by $0.68
Q2'25
Missed
by $0.11
Q1'25
Est.
$-0.65
Q4'24
Beat
by $0.16
The last earnings report on November 12 showed earnings per share of 27 cents, beating the estimate of -40 cents. With 223.77K shares outstanding, the current market capitalization sits at 88.56M.
A.I. Advisor
published General Information

General Information

a company, which engages in the discovery and development of monoclonal antibody-based therapeutics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
9704 Medical Center Drive
Phone
+1 301 251-5172
Employees
339
Web
https://www.macrogenics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LCGMF0.100.01
+5.80%
LION COPPER & GOLD CORP.
PEGRF6.150.06
+0.99%
Pennon Group PLC
NTOIF20.50N/A
N/A
Neste OYJ
PEFDF0.64N/A
N/A
DELFI LTD
NASC0.02N/A
N/A
Nascent Pharma Holdings Inc.

MGNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGNX has been loosely correlated with RGNX. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if MGNX jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGNX
1D Price
Change %
MGNX100%
+2.19%
RGNX - MGNX
53%
Loosely correlated
+8.56%
CRBU - MGNX
50%
Loosely correlated
N/A
BEAM - MGNX
49%
Loosely correlated
+7.82%
IDYA - MGNX
49%
Loosely correlated
+2.50%
ARWR - MGNX
48%
Loosely correlated
+6.20%
More